Literature DB >> 22021129

Radiation recall myositis in pediatric Ewing sarcoma.

Jona Hattangadi1, Brittany Esty, Brian Winey, Shauna Duigenan, Mary Huang, Torunn Yock.   

Abstract

Radiation recall is a rare and poorly understood phenomenon, characterized by an acute inflammatory reaction within the previously irradiated area, triggered by a precipitating systemic agent. This reaction typically affects the skin, and radiation recall myositis in the absence of cutaneous involvement has rarely been described in the literature. In this report, we present two cases of radiation recall in pediatric Ewing sarcoma patients receiving successive proton radiotherapy and chemotherapy, with magnetic resonance imaging (MRI) of muscle edema within the prior radiation fields.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22021129     DOI: 10.1002/pbc.23374

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  4 in total

1.  Pemetrexed-induced radiation recall dermatitis in a patient with lung adenocarcinoma: case report and literature review.

Authors:  Jin Ge; Vivek Verma; Andrew Hollander; Corey Langer; Charles B Simone
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

2.  Amyloid precursor-like protein 2 suppresses irradiation-induced apoptosis in Ewing sarcoma cells and is elevated in immune-evasive Ewing sarcoma cells.

Authors:  Haley L Peters; Ying Yan; Tara M Nordgren; Christine E Cutucache; Shantaram S Joshi; Joyce C Solheim
Journal:  Cancer Biol Ther       Date:  2013-06-26       Impact factor: 4.742

Review 3.  Clinical controversies: proton therapy for pediatric tumors.

Authors:  Thomas E Merchant
Journal:  Semin Radiat Oncol       Date:  2013-04       Impact factor: 5.934

Review 4.  Imaging of acute and subacute toxicities of cancer therapy in children.

Authors:  Govind B Chavhan; Paul S Babyn; Paul C Nathan; Sue C Kaste
Journal:  Pediatr Radiol       Date:  2015-10-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.